February 7, 2018 / 1:34 PM / 18 days ago

BRIEF-Advanced Proteome Therapeutics And Immunobiochem Enter Into Collaboration And Option Agreement

Feb 7 (Reuters) - Advanced Proteome Therapeutics Corp :

* ADVANCED PROTEOME THERAPEUTICS AND IMMUNOBIOCHEM CORPORATION ENTER INTO A COLLABORATION AND OPTION AGREEMENT

* ADVANCED PROTEOME THERAPEUTICS - CO, IMMUNOBIOCHEM ENTER INTO COLLABORATION AND OPTION AGREEMENT TO DEVELOP SUPERIOR ANTIBODY-DRUG CONJUGATES

* ADVANCED PROTEOME THERAPEUTICS - IMMUNOBIOCHEM GRANTED RIGHTS TO LICENSE PROPRIETARY SITE-SELECTIVE CONJUGATION TECHNOLOGY

* ADVANCED PROTEOME THERAPEUTICS CORP - PRE-NEGOTIATED LICENSING TERMS INCLUDE UPFRONT AND MILESTONE PAYMENTS AND ROYALTIES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below